Goyette P, Rozen R
Department of Human Genetics, Pediatrics and Biology, McGill University, Montreal Children's Hospital, Montreal, Canada.
Hum Mutat. 2000;16(2):132-8. doi: 10.1002/1098-1004(200008)16:2<132::AID-HUMU5>3.0.CO;2-T.
Methylenetetrahydrofolate reductase (MTHFR) catalyses the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a carbon donor for homocysteine remethylation to methionine. Severe MTHFR deficiency is associated with hyperhomocysteinemia and homocystinuria. These patients show a wide variety of neurological and vascular symptoms, with variable age of onset. Residual enzyme activity is usually less than 20% of control values, and correlates reasonably well with age of onset of symptoms. A milder deficiency of MTHFR, with 30%-50% residual enzyme activity and increased enzyme thermolability, has been described as a risk factor for vascular disease and for neural tube defects. In earlier work, we isolated the human cDNA for MTHFR, and reported 14 mutations in severe MTHFR deficiency, as well as a common 677C-->T missense mutation (Ala-->Val) that encodes the thermolabile MTHFR. This variant has also been observed in some patients with severe MTHFR deficiency, in cis with their severe mutations. We report here the in vitro expression of seven severe MTHFR mutations in a bacterial expression system; six of these were expressed in cis with the Val allele to mimic the situation in the patients. We show that three of these constructs have significantly reduced enzyme activity (<10% of control); the presence of the thermolabile variant in these patients in cis is unlikely to affect enzyme function since activity is already low. One mutation causes a dramatic increase in activity when it is expressed in cis with the Ala allele, but is associated with extreme lability when in cis with the Val allele. Three mutations cause moderate decreases in enzyme activity, with a further decrease in activity when they are in cis with the Val allele. We hypothesize that deleterious mutations which alter stability may be compromised to a greater degree when the thermolabile variant is present on the same allele.
亚甲基四氢叶酸还原酶(MTHFR)催化5,10 - 亚甲基四氢叶酸还原为5 - 甲基四氢叶酸,后者是同型半胱氨酸再甲基化生成甲硫氨酸的碳供体。严重的MTHFR缺乏与高同型半胱氨酸血症和同型胱氨酸尿症相关。这些患者表现出各种各样的神经和血管症状,发病年龄各异。残余酶活性通常低于对照值的20%,且与症状发病年龄有较好的相关性。MTHFR的轻度缺乏,即残余酶活性为30% - 50%且酶热稳定性增加,已被描述为血管疾病和神经管缺陷的危险因素。在早期工作中,我们分离出了人类MTHFR的cDNA,并报告了严重MTHFR缺乏中的14种突变,以及一个常见的677C→T错义突变(Ala→Val),该突变编码热不稳定的MTHFR。在一些严重MTHFR缺乏的患者中也观察到了这种变体,它与严重突变处于顺式状态。我们在此报告在细菌表达系统中7种严重MTHFR突变的体外表达;其中6种与Val等位基因处于顺式状态表达,以模拟患者中的情况。我们表明,这些构建体中的3种具有显著降低的酶活性(<对照值的10%);这些患者中与热不稳定变体处于顺式状态不太可能影响酶功能,因为活性已经很低。一种突变在与Ala等位基因处于顺式状态表达时会导致活性急剧增加,但与Val等位基因处于顺式状态时则与极端不稳定性相关。3种突变导致酶活性适度降低,与Val等位基因处于顺式状态时活性进一步降低。我们推测,当热不稳定变体存在于同一等位基因上时,改变稳定性的有害突变可能会受到更大程度的损害。